Literature DB >> 4202670

Studies on derivation of transcobalamin 3 from granulocytes. Enhancement by lithium and elimination by fluoride of in vitro increments in vitamin B12-binding capacity.

J M Scott, F J Bloomfield, R Stebbins, V Herbert.   

Abstract

Unsaturated vitamin B(12)-binding capacity (UBBC) of human serum is not reproducibly measurable because it increases variably in vitro in relation to time, temperature, and, in the case of plasma, anticoagulant present before removal of cells. This variable increase proved to be due to variable release in vitro of transcobalamin III (TC III) from granulocytes. UBBC increase was greatest (up to fourfold normal levels) in the presence of lithium, which is the heparin salt used in many laboratories doing UBBC studies. In vitro increase was least when blood was collected in EDTA at 0 degrees C and immediately centrifuges at 0 degrees C (T(0) sample); results equivalent to T(0) were obtained at room temperature even after several hours delay when 47 mM fluoride was present; either cold temperature or 47 mM fluoride appeared to prevent TC III release from granulocytes. The measured levels of the three transcobalamins with T(0) methods of collection, which presumably reflect most closely the in vivo circulating levels, suggest that TC I and TC III in normal plasms are of the same order of magnitude and together normally comprise less than 10% of the UBBC. Approximately 90% of the UBBC content of sonicates of peripheral blood granulocytes and of bone marrow aspirates of normal individuals appears to be TC III, with the rest being TC I. Thus, normal myelocytes, like normal granulocytes, appear to contain mainly TC III. No TC II was present in any of the sonicates. The general practice in most laboratories has been to determine serum UBBC. Because in vitro increments of up to 119% were found to occur in serum, this practice should be replaced by collection using methods that prevent such increments. Blood collected in EDTA-47 mM NaF had a stable, reproducible UBBC with no significant in vitro increment with time.EDTA-NaF UBBC was 640+/-168 (range 380-921 pg B(12) bound/ml plasma) for 12 normal adult men and 809+/-232 (range 505-1208) for normal adult women. It presumably approximates circulating UBBC and is substantially below the serum UBBC mean of 935+/-262 (range 611-1506 for the same 12 men) and 1273+/-355 (range 811-2306 for the same 10 women).

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4202670      PMCID: PMC301458          DOI: 10.1172/JCI107543

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  The effect of anticoagulants on the in vitro binding capacity of serum and plasma for cobalamins.

Authors:  E H Kennedy; J F Adams
Journal:  Scand J Haematol       Date:  1967-12

2.  Influence of plasma preparation technique on the amount of recovered B 12 -binding proteins.

Authors:  R Gullberg
Journal:  Clin Chim Acta       Date:  1971-06       Impact factor: 3.786

3.  Serum vitamin B12 content and unsaturated vitamin B12-binding capacity in myeloproliferative disease. Value in differential diagnosis and as indicators of disease activity.

Authors:  H S Gilbert; S Krauss; B Pasternack; V Herbert; L R Wasserman
Journal:  Ann Intern Med       Date:  1969-10       Impact factor: 25.391

4.  A 57Co vitamin B12 binder in normal serum eluted by DEAE-cellulose chromatography with 0. 1m sodium phosphate buffer, pH 5.8.

Authors:  E J Gizis; M F Dietrich; G Ohoi; L M Meyer
Journal:  J Lab Clin Med       Date:  1970-04

5.  Serum transcobalamin in myeloid leukemia.

Authors:  B Rachmilewitz; M Rachmilewitz; B Moshkowitz; J Gross
Journal:  J Lab Clin Med       Date:  1971-08

6.  Correation between vario blood white cell pools and the serum B12-binding capaities.

Authors:  G Chikkappa; J Corcino; M L Greenerg; V Herert
Journal:  Blood       Date:  1971-02       Impact factor: 22.113

7.  Complexing of transcobalamin 2 and apparent combination with heparin.

Authors:  B A Cooper
Journal:  Blood       Date:  1970-06       Impact factor: 22.113

8.  Separation of vitamin B 12-binding proteins of serum, gastric juice and saliva by rapid DEAE cellulose chromatography.

Authors:  F P Retief; C W Gottlieb; S Kochwa; P W Pratt; V Herbert
Journal:  Blood       Date:  1967-04       Impact factor: 22.113

9.  Measurement of the amounts of the individual vitamin B12 binding proteins in plasma. 1. Studies of normal plasma.

Authors:  C A Hall; A E Finkler
Journal:  Blood       Date:  1966-05       Impact factor: 22.113

10.  Release of vitamin B12--binding protein by human leukocytes in vitro.

Authors:  J Corcino; S Krauss; S Waxman; V Herbert
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

View more
  8 in total

1.  Effect of lithium therapy on inflammatory response.

Authors:  J W O'Riordan; D Kelleher; Y Williams; F J Bloomfield
Journal:  Inflammation       Date:  1986-03       Impact factor: 4.092

2.  Isolation and characterization of a novel vitamin B12-binding protein associated with hepatocellular carcinoma.

Authors:  R L Burger; S Waxman; H S Gilbert; C S Mehlman; R H Allen
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

3.  Absorption, plasma transport, and cellular retention of cobalamin analogues in the rabbit. Evidence for the existence of multiple mechanisms that prevent the absorption and tissue dissemination of naturally occurring cobalamin analogues.

Authors:  J F Kolhouse; R H Allen
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

4.  The role and fate of rabbit and human transcobalamin II in the plasma transport of vitamin B12 in the rabbit.

Authors:  R J Schneider; R L Burger; C S Mehlman; R H Allen
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

5.  Detection of genetic variation with radioactive ligands. III. genetic polymorphism of transcobalamin II in human plasma.

Authors:  S P Daiger; M L Labowe; M Parsons; L Wang; L L Cavalli-Sforza
Journal:  Am J Hum Genet       Date:  1978-03       Impact factor: 11.025

6.  Influence of lithium and fluoride on degranulation from human neutrophils in vitro.

Authors:  F J Bloomfield; M M Young
Journal:  Inflammation       Date:  1982-09       Impact factor: 4.092

7.  Limitations of protein-coated charcoal in the separation of free from bound vitamin B12 in serum.

Authors:  E Jacob; K T Wong
Journal:  J Clin Pathol       Date:  1983-09       Impact factor: 3.411

8.  Inheritance and genetic linkage of transcobalamin II.

Authors:  S Y Yang; P Coleman; H D Ochs; B Dupont
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.